| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3317938 | Pancreatology | 2012 | 5 Pages |
Abstract
Capecitabine combined with thalidomide is a well-tolerated second-line regimen, in patients with APC refractory to gemcitabine.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Sheng-bin Shi, Meng Wang, Zuo-xing Niu, Xiao-yong Tang, Quan-yun Liu,